Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Daniel Y Joh"'
Autor:
Daniel Y Joh, Lova Sun, Melissa Stangl, Ajlan Al Zaki, Surya Murty, Phillip P Santoiemma, James J Davis, Brian C Baumann, Michelle Alonso-Basanta, Dongha Bhang, Gary D Kao, Andrew Tsourkas, Jay F Dorsey
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e62425 (2013)
Successful treatment of brain tumors such as glioblastoma multiforme (GBM) is limited in large part by the cumulative dose of Radiation Therapy (RT) that can be safely given and the blood-brain barrier (BBB), which limits the delivery of systemic ant
Externí odkaz:
https://doaj.org/article/920268b6f79d4dd88dcb5239e0d48431
Autor:
Daniel Y. Joh, Jacob T. Heggestad, Shengwei Zhang, Grace R. Anderson, Jayanta Bhattacharyya, Suzanne E. Wardell, Simone A. Wall, Amy B. Cheng, Faris Albarghouthi, Jason Liu, Sachi Oshima, Angus M. Hucknall, Terry Hyslop, Allison H. S. Hall, Kris C. Wood, E. Shelley Hwang, Kyle C. Strickland, Qingshan Wei, Ashutosh Chilkoti
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-14 (2021)
Abstract Management of breast cancer in limited-resource settings is hindered by a lack of low-cost, logistically sustainable approaches toward molecular and cellular diagnostic pathology services that are needed to guide therapy. To address these li
Externí odkaz:
https://doaj.org/article/dbe9959994e64aa882ef7c71873c21a5
Autor:
Jacob T. Heggestad, Rhett J. Britton, David S. Kinnamon, Jason Liu, Jack G. Anderson, Daniel Y. Joh, Zachary Quinn, Cassio M. Fontes, Angus M. Hucknall, Robert Parks, Gregory D. Sempowski, Thomas N. Denny, Thomas W. Burke, Barton F. Haynes, Christopher W. Woods, Ashutosh Chilkoti
Publikováno v:
Analytical Chemistry. 95:5610-5617
Autor:
Daniel Y. Joh, Jacob T. Heggestad, Shengwei Zhang, Grace R. Anderson, Jayanta Bhattacharyya, Suzanne E. Wardell, Simone A. Wall, Amy B. Cheng, Faris Albarghouthi, Jason Liu, Sachi Oshima, Angus M. Hucknall, Terry Hyslop, Allison H. S. Hall, Kris C. Wood, E. Shelley Hwang, Kyle C. Strickland, Qingshan Wei, Ashutosh Chilkoti
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/1dfb4707594c49eb8cecb51f6505fc5d
Autor:
Bruce A. Sullenger, Anna Mazur, Thomas H. Oguin, David Kinnamon, Cameron R. Wolfe, Daniel Y. Joh, Ashutosh Chilkoti, Christopher W. Woods, Rhett J Britton, Jacob T Heggestad, Angus Hucknall, Lyra B. Olson, Jack G. Anderson, Bryan Kraft, Gregory D. Sempowski, Thomas W. Burke, Simone A. Wall
Publikováno v:
Science Advances
Description
A rapid test measures neutralizing antibodies against SARS-CoV-2 variants of concern in 1 hour.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants are concerning in the ongoing coronavirus disease 2019 (COVID-
A rapid test measures neutralizing antibodies against SARS-CoV-2 variants of concern in 1 hour.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants are concerning in the ongoing coronavirus disease 2019 (COVID-
Autor:
David Kinnamon, Qingshan Wei, Aydogan Ozcan, Angus Hucknall, Jason Liu, Cassio M. Fontes, Daniel Y. Joh, Ashutosh Chilkoti, Jacob T Heggestad
Publikováno v:
Methods in Molecular Biology ISBN: 9781071618028
Sandwich immunoassays are the gold standard for detection of protein analytes. Here, we describe an ultrasensitive point-of-care sandwich immunoassay platform for the detection of biomarkers directly from blood or serum using a custom-built smartphon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::baf53f8410068d2269218bc6a52939b9
https://doi.org/10.1007/978-1-0716-1803-5_19
https://doi.org/10.1007/978-1-0716-1803-5_19
Autor:
Patricia Shi, Krystle N. Agans, Daniel Y. Joh, Daniela F. Cruz, Thomas W. Geisbert, Carl F. Pieper, Maiken H. Mikkelsen, Michael D. Gunn, Cassio M. Fontes, Roarke Horstmeyer, Kelli M. Luginbuhl, Angus Hucknall, Stephanie L. Foster, Barbara D. Lipes, Garrett Kelly, Ashutosh Chilkoti, Jacob T Heggestad, Jason Liu, Aiwei Yan
Publikováno v:
Sci Transl Med
Ebola virus (EBOV) hemorrhagic fever outbreaks have been challenging to deter due to the lack of health care infrastructure in disease-endemic countries and a corresponding inability to diagnose and contain the disease at an early stage. EBOV vaccine
Autor:
Simone A. Wall, Christopher W. Woods, Jack G. Anderson, Lyra B. Olson, Gregory D. Sempowski, Carl F. Pieper, Bryan Kraft, Daniel Y. Joh, David Kinnamon, Thomas H. Oguin, Smita K. Nair, Lingye Chen, Garrett Kelly, Thomas W. Burke, Zachary Quinn, Ashutosh Chilkoti, Loretta G. Que, Jacob T Heggestad, Angus Hucknall, Solomon Oshabaheebwa, Cassio M. Fontes, Jason Liu, Bruce A. Sullenger, Ibtehaj A. Naqvi
Publikováno v:
medRxiv
article-version (status) pre
article-version (number) 1
Science Advances
article-version (status) pre
article-version (number) 1
Science Advances
A point-of-care, microfluidic platform detects antibodies against three SARS-CoV-2 antigens from blood in less than an hour.
Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disea
Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage coronavirus disea
Autor:
Allison Hall, Simone A. Wall, Amy B. Cheng, Ashutosh Chilkoti, Qingshan Wei, Grace R. Anderson, E. Shelley Hwang, Jason Liu, Daniel Y. Joh, Jacob T Heggestad, Faris Albarghouthi, Kris C. Wood, Suzanne E. Wardell, Terry Hyslop, Shengwei Zhang, Sachi Oshima, Angus Hucknall, Jayanta Bhattacharyya, Kyle C. Strickland
Publikováno v:
NPJ Breast Cancer
npj Breast Cancer, Vol 7, Iss 1, Pp 1-14 (2021)
npj Breast Cancer, Vol 7, Iss 1, Pp 1-14 (2021)
Management of breast cancer in limited-resource settings is hindered by a lack of low-cost, logistically sustainable approaches toward molecular and cellular diagnostic pathology services that are needed to guide therapy. To address these limitations
Autor:
Ashutosh Chilkoti, Carl F. Pieper, Gregory D. Sempowski, Daniel Y. Joh, Lyra B. Olson, Jacob T Heggestad, Garrett Kelly, Simone A. Wall, Bryan Kraft, Thomas H. Oguin, Christopher W. Woods, Ibtehaj A. Naqvi, Angus Hucknall, Bruce A. Sullenger, Loretta G. Que, David Kinnamon, Jason Liu, Lingye Chen, Cassio M. Fontes, Smita K. Nair
Highly sensitive, specific, and point-of-care (POC) serological assays are an essential tool to manage the COVID-19 pandemic. Here, we report on a microfluidic, multiplexed POC test that can profile the antibody response against multiple SARS-CoV-2 a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22a0b7ad11458d61a2d6dae66d29596c
https://doi.org/10.1101/2020.11.05.20226654
https://doi.org/10.1101/2020.11.05.20226654